コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
3 nt effects of epinephrine (10 micromol/L) or zinterol (10 micromol/L), mediated through beta2-adrener
5 ees C), beta(2)-AR stimulation (1 micromol/L zinterol+300 nmol/L beta(1)-AR antagonist CGP-29712A) in
6 atenolol (a beta1-adrenergic antagonist), or zinterol (a beta2-adrenergic antagonist) administered bi
8 or = formoterol = fenoterol > terbutaline = zinterol = albuterol > salmeterol > dobutamine > or = ep
11 ases in the potency of ISO, epinephrine, and zinterol, but not of norepinephrine, and a 20-40% loss i
14 ses of the beta2-adrenergic receptor agonist zinterol on Ca2+ transient amplitudes were examined in v
16 of Gi2 and Gi3 after beta2AR stimulation by zinterol or isoproterenol plus the beta1AR blocker CGP 2
17 ediated by most beta2-AR agonists, including zinterol, salbutamol, and procaterol, was potentiated by
18 In addition, the beta2-adrenoceptor agonist zinterol significantly increased peak IBa while the beta
19 tration of the beta2AR agonists fenoterol or zinterol, starting at 2 weeks after MI, reduced the exte
22 lol (ISO-beta(2)-AR stimulation) or 1 microM zinterol (ZIN-beta(2)-AR stimulation) increased I(Ca,L),